ROBERT F GAGEL to Multiple Endocrine Neoplasia
This is a "connection" page, showing publications ROBERT F GAGEL has written about Multiple Endocrine Neoplasia.
Connection Strength
1.804
-
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Early thyroidectomy in multiple endocrine neoplasia: a four decade experience. Endocr Relat Cancer. 2020 08; 27(8):T1-T8.
Score: 0.737
-
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The state of science in medullary thyroid carcinoma: current challenges and unmet needs. Endocr Relat Cancer. 2020 08; 27(8):T27-T39.
Score: 0.184
-
Multiple endocrine neoplasias. Annu Rev Physiol. 2000; 62:377-411.
Score: 0.177
-
Pheochromocytoma, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med. 1994 Apr 14; 330(15):1090-1.
Score: 0.119
-
The role of genetic screening in the management of hereditary malignancy. Horm Metab Res. 1993 Sep; 25(9):481-3.
Score: 0.114
-
Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med. 1989 Nov 15; 111(10):802-6.
Score: 0.088
-
Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant. Henry Ford Hosp Med J. 1989; 37(3-4):147-50.
Score: 0.083
-
The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. N Engl J Med. 1988 Feb 25; 318(8):478-84.
Score: 0.078
-
Impact of prospective screening for multiple endocrine neoplasia type 2. Henry Ford Hosp Med J. 1987; 35(2-3):94-8.
Score: 0.072
-
Screening for MEN 2 with biochemical and genetic markers. Recent Results Cancer Res. 1992; 125:105-23.
Score: 0.025
-
A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A. Henry Ford Hosp Med J. 1992; 40(3-4):205-9.
Score: 0.025
-
Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinol Metab Clin North Am. 1990 Sep; 19(3):613-35.
Score: 0.023
-
The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet. 1989 Feb; 44(2):208-15.
Score: 0.021
-
Risk estimation and screening in families of patients with medullary thyroid carcinoma. Lancet. 1988 Feb 20; 1(8582):397-401.
Score: 0.019
-
Thyroid carcinoma. J Natl Compr Canc Netw. 2005 May; 3(3):404-57.
Score: 0.016
-
Surgical management of hereditary pheochromocytoma. J Am Coll Surg. 2004 Apr; 198(4):525-34; discussion 534-5.
Score: 0.015
-
Direct sequencing of PCR products in agarose gel slices. Nucleic Acids Res. 1994 Aug 25; 22(16):3425-6.
Score: 0.008